Tariq Ghayur PhD

Tariq Ghayur received a Ph.D (1986) in Immunology from Department of Physiology, McGill University, Montreal, Canada. He did his post-doctoral training at McGill (1986-’88) and Dana Farber Cancer Institute (1988-’90). He joined BASF Pharma (1990), which was acquired by Abbott Laboratories.

He has worked on both small molecule and therapeutic antibody discovery programs, mainly defining the biology/pathology of selected targets (target validation) and developing assays for high throughput screening and/or candidate selection. From 1998-2004, he led two therapeutic antibody discovery project teams and delivered 2 drug development candidates.

Dr. Ghayur received Abbott’s “President’s Award” in 2004, 2008 and 2009 and Abbott's "Chairman's Award" in 2008 for his various contributions. As a member of the Volwiler Society at Abbott, Dr. Ghayur has worked on various initiatives that encourage and enable scientists, at all levels of the organization, to explore novel ideas to initiate new drug discovery programs and/or develop novel technologies.